We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

CureVac’s Covid-19 Vaccine Disappoints in Clinical Trial


A preliminary analysis showed that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said.
read more

Source: NY Times


00:05, June 17, 2021 Carl Zimmer

You may also like

News